BiotechTube
Home/Vyluma/George Zorich
GZ

George Zorich

Chairman & CEO

Vyluma

Therapeutic Areas

OphthalmologyPediatric MyopiaRefractive Errors

Vyluma Pipeline

DrugIndicationPhase
NVK002Pediatric Myopia (progression)Phase 3
NVK029PresbyopiaPhase 2
NVK031Night Vision DisturbanceProof-of-Concept

Leadership Team at Vyluma

HH
Houman Hemmati, MD, PhD
Chief Medical Affairs Officer
TM
Tung M. Fong, PhD
Vice President, Clinical Development
View full Vyluma profile